Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for synthesizing furazanobenzimidazoles result in amorphous solids, which are challenging for pharmaceutical processing, and use of benzyloxy carbamate protecting groups leads to suboptimal yields and purities.
Innovation Solution
The use of tert-butyl carbamate protecting groups and specific reaction conditions to obtain crystalline forms of the dichloride salt of furazanobenzimidazoles, allowing for improved yield and purity, and the development of crystallization methods to achieve polymorphic forms suitable for pharmaceutical formulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If benzyloxy carbamate protecting groups are used in the synthesis process, then the amino groups can be protected, but the yields and purities are suboptimal
Solution Approach 1:
The patent changes the protecting group from benzyloxy carbamate to tert-butyl carbamate (Boc), which fundamentally alters the reaction parameters and conditions. This substitution enables better control over the synthesis process, resulting in improved yields and purities of the furazanobenzimidazole compounds.
2Ease of manufacture
If conventional synthesis procedures are used, then the compound can be produced, but it is isolated as an amorphous solid which is challenging for pharmaceutical processing
Solution Approach 1:
The patent employs specific crystallization procedures that induce phase transition from amorphous to crystalline form. By controlling the crystallization conditions (solvent selection, temperature, pH), the compound is obtained as a crystalline solid, which possesses superior properties for pharmaceutical processing including stability, solubility, and manufacturability.
3Stability of the object's composition
If amorphous solid form is obtained, then the synthesis is simpler, but the stability and solubility are reduced
Solution Approach 1:
The patent optimizes multiple parameters including solvent selection, temperature control, pH adjustment, and addition rate during crystallization. These parameter changes enable the formation of stable crystalline structures with improved stability and solubility characteristics, while maintaining process feasibility through systematic optimization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The crystalline forms provide enhanced stability, solubility, and processing advantages, enabling more effective pharmaceutical applications.
Implementation Method 1
comprising deprotecting a compound of formula II
Implementation Method 2
the dichloride salt of the compound of formula I can be isolated in crystalline form
Data Source
AI summary
The present invention provides processes for preparing a compound of formula I and pharmaceutically acceptable salts thereof,comprising deprotecting a compound of formula IIwherein each R3 independently represents a tertiary alkyl group, preferably wherein each R3 is tertiary butyl. The invention also provides intermediates useful for preparing compounds of formula I and processes for preparing these intermediates. Additionally the invention provides polymorphic forms of the dichloride salt of the compound of formula I and their use in the treatment of proliferative disorders.